Correlation Between Johnson Johnson and Entia Biosciences

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Johnson Johnson and Entia Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Johnson Johnson and Entia Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Johnson Johnson and Entia Biosciences, you can compare the effects of market volatilities on Johnson Johnson and Entia Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Johnson Johnson with a short position of Entia Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Johnson Johnson and Entia Biosciences.

Diversification Opportunities for Johnson Johnson and Entia Biosciences

-0.62
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Johnson and Entia is -0.62. Overlapping area represents the amount of risk that can be diversified away by holding Johnson Johnson and Entia Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Entia Biosciences and Johnson Johnson is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Johnson Johnson are associated (or correlated) with Entia Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Entia Biosciences has no effect on the direction of Johnson Johnson i.e., Johnson Johnson and Entia Biosciences go up and down completely randomly.

Pair Corralation between Johnson Johnson and Entia Biosciences

Considering the 90-day investment horizon Johnson Johnson is expected to under-perform the Entia Biosciences. But the stock apears to be less risky and, when comparing its historical volatility, Johnson Johnson is 5.96 times less risky than Entia Biosciences. The stock trades about -0.01 of its potential returns per unit of risk. The Entia Biosciences is currently generating about 0.01 of returns per unit of risk over similar time horizon. If you would invest  0.03  in Entia Biosciences on September 5, 2024 and sell it today you would lose (0.01) from holding Entia Biosciences or give up 33.33% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Johnson Johnson  vs.  Entia Biosciences

 Performance 
       Timeline  
Johnson Johnson 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Johnson Johnson has generated negative risk-adjusted returns adding no value to investors with long positions. Even with latest weak performance, the Stock's basic indicators remain steady and the new chaos on Wall Street may also be a sign of medium-term gains for the company stakeholders.
Entia Biosciences 

Risk-Adjusted Performance

9 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Entia Biosciences are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of very fragile technical and fundamental indicators, Entia Biosciences displayed solid returns over the last few months and may actually be approaching a breakup point.

Johnson Johnson and Entia Biosciences Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Johnson Johnson and Entia Biosciences

The main advantage of trading using opposite Johnson Johnson and Entia Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Johnson Johnson position performs unexpectedly, Entia Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Entia Biosciences will offset losses from the drop in Entia Biosciences' long position.
The idea behind Johnson Johnson and Entia Biosciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.

Other Complementary Tools

Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings